Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP442330.RA9XHKS8QsuQLmVqdYntyiaq7fEXgFg0Gq0qbnorvctLE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP442330.RA9XHKS8QsuQLmVqdYntyiaq7fEXgFg0Gq0qbnorvctLE130_assertion type Assertion NP442330.RA9XHKS8QsuQLmVqdYntyiaq7fEXgFg0Gq0qbnorvctLE130_head.
- NP442330.RA9XHKS8QsuQLmVqdYntyiaq7fEXgFg0Gq0qbnorvctLE130_assertion wasGeneratedBy ECO_0000203 NP442330.RA9XHKS8QsuQLmVqdYntyiaq7fEXgFg0Gq0qbnorvctLE130_provenance.
- NP442330.RA9XHKS8QsuQLmVqdYntyiaq7fEXgFg0Gq0qbnorvctLE130_assertion wasDerivedFrom befree-20140225 NP442330.RA9XHKS8QsuQLmVqdYntyiaq7fEXgFg0Gq0qbnorvctLE130_provenance.
- NP442330.RA9XHKS8QsuQLmVqdYntyiaq7fEXgFg0Gq0qbnorvctLE130_assertion SIO_000772 17372243 NP442330.RA9XHKS8QsuQLmVqdYntyiaq7fEXgFg0Gq0qbnorvctLE130_provenance.
- NP442330.RA9XHKS8QsuQLmVqdYntyiaq7fEXgFg0Gq0qbnorvctLE130_assertion evidence source_evidence_literature NP442330.RA9XHKS8QsuQLmVqdYntyiaq7fEXgFg0Gq0qbnorvctLE130_provenance.
- NP442330.RA9XHKS8QsuQLmVqdYntyiaq7fEXgFg0Gq0qbnorvctLE130_assertion description "[CYP1B1 Leu(432) carriers were at increased risk of ovarian cancer, with an adjusted OR of 1.5 (95% confidence interval, 1.1-2.3) compared with Val(432) homozygotes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442330.RA9XHKS8QsuQLmVqdYntyiaq7fEXgFg0Gq0qbnorvctLE130_provenance.